SCHEMBL31504026

SCHEMBL31504026

O=C(Nc1ccc(Oc2ccc(C(=O)O)cc2)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 8/20 0.68
CDK8 P49336 3/20 0.67
RAF1 P04049 8/20 0.67
BRAF P15056 2/20 0.66
FLT1 P17948 2/20 0.65
EPHX2 P34913 3/20 0.64
CA7 P43166 2/20 0.64
CA9 Q16790 2/20 0.64
CA1 P00915 1/20 0.64
CA2 P00918 1/20 0.64
FAAH O00519 1/20 0.63
MEN1 O00255 1/20 0.61
PLK4 O00444 1/20 0.61
CIT O14578 1/20 0.61
AURKA O14965 1/20 0.61
MUSK O15146 1/20 0.61
EPHB6 O15197 1/20 0.61
MAPK13 O15264 1/20 0.61
MLNR O43193 1/20 0.61
MAP3K7 O43318 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16621058 1.00 KDR (0.68) KDRCDK8RAF1BRAFFLT1
SCHEMBL716399 0.92 KDR (0.80) KDRCDK8RAF1EPHX2CA7
SCHEMBL13556629 0.90 RAF1 (0.72) KDRCDK8RAF1BRAFFLT1
SCHEMBL6014335 0.90 RAF1 (0.79) KDRCDK8RAF1FLT1EPHX2
SCHEMBL6014647 0.88 RAF1 (0.80) KDRCDK8RAF1BRAFFLT1
SCHEMBL16628140 0.86 KDR (0.70) KDRCDK8RAF1BRAFFLT1
SCHEMBL938819 0.86 KDR (0.70) KDRCDK8RAF1BRAFFLT1
SCHEMBL936533 0.85 RAF1 (0.73) KDRCDK8RAF1BRAFFLT1
SCHEMBL30462521 0.85 RAF1 (0.73) KDRCDK8RAF1BRAFFLT1
SCHEMBL16621046 0.84 KDR (0.67) KDRCDK8RAF1BRAFFLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025083280-A1 SORAFENIB ANALOGS FOR USE IN THE TREATMENT OF CANCER UNIVERSITAT DE BARCELONA (ES) 2025-04-24 WO disclosed